MBGPF (Moberg Pharma AB) Days Sales Outstanding : 254.13 (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Moberg Pharma AB Days Sales Outstanding?

Moberg Pharma AB's average Accounts Receivable for the three months ended in Dec. 2024 was $0.26 Mil. Moberg Pharma AB's Revenue for the three months ended in Dec. 2024 was $0.09 Mil. Hence, Moberg Pharma AB's Days Sales Outstanding for the three months ended in Dec. 2024 was 254.13.

The historical rank and industry rank for Moberg Pharma AB's Days Sales Outstanding or its related term are showing as below:

MBGPF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 6.18 Med: 55.76 Max: 5395.23
Current: 235.55

During the past 13 years, Moberg Pharma AB's highest Days Sales Outstanding was 5395.23. The lowest was 6.18. And the median was 55.76.

MBGPF's Days Sales Outstanding is ranked worse than
95.1% of 960 companies
in the Drug Manufacturers industry
Industry Median: 72.36 vs MBGPF: 235.55

Moberg Pharma AB's Days Sales Outstanding increased from Dec. 2023 (0.00) to Dec. 2024 (254.13).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Moberg Pharma AB Days Sales Outstanding Historical Data

The historical data trend for Moberg Pharma AB's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Days Sales Outstanding Chart

Moberg Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

812.13

6.13

Moberg Pharma AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															-	340.74	222.42	256.44	254.13

Competitive Comparison of Moberg Pharma AB's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moberg Pharma AB's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Moberg Pharma AB Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Moberg Pharma AB's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0	+	0.015)	/	1 )	/	0.893	*	365
=	0.015					/	0.893	*	365
=	6.13

Moberg Pharma AB's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0.503	+	0.015)	/	2 )	/	0.093	*	365 / 4
=	0.259					/	0.093	*	365 / 4
=	254.13

Moberg Pharma AB (OTCPK:MBGPF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Moberg Pharma AB Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Moberg Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OTCPK:MBGPF) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

MOB:Sweden

Address

Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51

Website

https://www.mobergpharma.se

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.